Key statistics
As of last trade, BioNexus Gene Lab Corp (BGLC:NAQ) traded at 0.4398, 41.87% above the 52 week low of 0.31 set on Nov 15, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.421 |
---|---|
High | 0.4398 |
Low | 0.415 |
Bid | 0.415 |
Offer | 0.4268 |
Previous close | 0.4038 |
Average volume | 2.24m |
---|---|
Shares outstanding | 17.97m |
Free float | 6.89m |
P/E (TTM) | -- |
Market cap | 7.26m USD |
EPS (TTM) | -0.1108 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 15:20 BST.
More ▼
- BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
- BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions
- BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production
- BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd
- BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd
- BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
More ▼